Literature DB >> 12932903

Synthesis of quaternised 2-aminopyrimido[4,5-d]pyrimidin-4(3H)-ones and their biological activity with dihydrofolate reductase.

Markus G Gebauer1, Carolyn McKinlay, Jill E Gready.   

Abstract

In a program to design and develop mechanism-based compounds active as substrates and inhibitors of dihydrofolate reductase (DHFR), we report the synthesis and physical properties of the 6-methyl- (7), 8-methyl- (8a), and 8-ethyl- (8b) derivatives of the parent 2-aminopyrimido[4,5-d]pyrimidin-4-(3H)-one (6). These compounds are the first members of a class of heterocycles related to 8-alkylpterins (N8-alkyl-2-aminopteridin-4(8H)-ones) (2a-2c), which have been shown to be novel substrates for DHFR. Three methods were developed for the synthesis of target compounds 7, 8a and 8b; however, the optimum yields (1-8%) could not be improved because the products decomposed by ring opening (e.g. to 2,4-diamino-5-methyliminomethylpyrimidin-6(1H)-one (9)) under the reaction conditions. The marked pi-electron deficiency of compounds 7, 8a and 8b is the likely cause for the susceptibility of the quaternised pyrimidine ring in the related cations 10, 15a and 15b, respectively, to add nucleophiles, thus promoting the opening of the pyrimidopyrimidine ring system. 1H-NMR spectroscopic studies of compounds 7, 8a and 8b revealed a fast and reversible covalent hydration of the associated cations across the C7z.sbnd;N8 bond for the N6-methyl derivative 7 and across the N6z.sbnd;C7 bond for the N8-methyl derivative 8a. UV spectroscopic studies of methyl derivatives 7 and 8a as well as the parent heterocycle 6 showed that protonation of the latter occurred at N1, while methylation with iodomethane proceeded at N6 and N8. The basicities of the N-methyl derivatives 7 and 8a (pK(a) ca. 5.5) are similar to those of 8-alkylpterins 2; this is an essential element of the design to promote binding to DHFR in their protonated form. Enzyme kinetics of 7, 8a and 8b with chicken DHFR confirmed our predictions that they are substrates, with apparent K(m) values of 3.8, 0.08, and 0.65 mM, and apparent V(max) values of 0.47, 2.27, and 0.30 nmol L(-1) min(-1) (for enzyme concentration 0.122 micro M), respectively. The parent compound 6 was not a substrate.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12932903     DOI: 10.1016/s0223-5234(03)00140-5

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  10 in total

1.  Design, Synthesis and Biological Evaluation of Novel Pyrimido[4,5-d]pyrimidine CDK2 Inhibitors as Anti-Tumor Agents.

Authors:  Samir M El-Moghazy; Diaa A Ibrahim; Nagwa M Abdelgawad; Nahla A H Farag; Ahmad S El-Khouly
Journal:  Sci Pharm       Date:  2011-05-08

2.  Screening the Medicines for Malaria Venture Pathogen Box across Multiple Pathogens Reclassifies Starting Points for Open-Source Drug Discovery.

Authors:  Sandra Duffy; Melissa L Sykes; Amy J Jones; Todd B Shelper; Moana Simpson; Rebecca Lang; Sally-Ann Poulsen; Brad E Sleebs; Vicky M Avery
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 3.  Bicyclic 6 + 6 systems: the chemistry of pyrimido[4,5-d]pyrimidines and pyrimido[5,4-d]pyrimidines.

Authors:  M Monier; Doaa Abdel-Latif; Ahmed El-Mekabaty; Khaled M Elattar
Journal:  RSC Adv       Date:  2019-09-30       Impact factor: 4.036

Review 4.  Advances in the chemical and biological diversity of heterocyclic systems incorporating pyrimido[1,6-a]pyrimidine and pyrimido[1,6-c]pyrimidine scaffolds.

Authors:  Khaled M Elattar; Başak Doğru Mert; M Monier; Ahmed El-Mekabaty
Journal:  RSC Adv       Date:  2020-04-20       Impact factor: 4.036

Review 5.  Recyclization of Maleimides by Binucleophiles as a General Approach for Building Hydrogenated Heterocyclic Systems.

Authors:  Dmitriy Yu Vandyshev; Khidmet S Shikhaliev
Journal:  Molecules       Date:  2022-08-18       Impact factor: 4.927

6.  A Computational QSAR, Molecular Docking and In Vitro Cytotoxicity Study of Novel Thiouracil-Based Drugs with Anticancer Activity against Human-DNA Topoisomerase II.

Authors:  Doaa M Khaled; Mohamed E Elshakre; Mahmoud A Noamaan; Haider Butt; Marwa M Abdel Fattah; Dalia A Gaber
Journal:  Int J Mol Sci       Date:  2022-10-05       Impact factor: 6.208

7.  Leishmania donovani Growth Inhibitors from Pathogen Box Compounds of Medicine for Malaria Venture.

Authors:  Markos Tadele; Solomon M Abay; Eyasu Makonnen; Asrat Hailu
Journal:  Drug Des Devel Ther       Date:  2020-03-31       Impact factor: 4.162

8.  7'-Amino-1'H-spiro-[cyclo-heptane-1,2'-pyrimido[4,5-d]pyrimidin]-4'(3'H)-one.

Authors:  Shu Chen; Daxin Shi; Mingxing Liu; Jiarong Li
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-07-25

9.  Facile construction of substituted pyrimido[4,5-d]pyrimidones by transformation of enaminouracil.

Authors:  Wafaa S Hamama; Mohamed A Ismail; Hanaa A Al-Saman; Hanafi H Zoorob
Journal:  J Adv Res       Date:  2012-05-16       Impact factor: 10.479

10.  Synthesis of Densely Functionalized Pyrimidouracils by Nickel(II)-Catalyzed Isocyanide Insertion.

Authors:  Jurriën W Collet; Bénédicte Morel; Hung-Chien Lin; Thomas R Roose; Pieter Mampuys; Romano V A Orru; Eelco Ruijter; Bert U W Maes
Journal:  Org Lett       Date:  2020-01-16       Impact factor: 6.005

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.